CDMO
Income statement / Annual
Last year (2024), Avid Bioservices, Inc.'s total revenue was $139.91 M,
a decrease of 6.27% from the previous year.
In 2024, Avid Bioservices, Inc.'s net income was -$140.75 M.
See Avid Bioservices, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
04/30/2024 |
04/30/2023 |
04/30/2022 |
04/30/2021 |
04/30/2020 |
04/30/2019 |
04/30/2018 |
04/30/2017 |
04/30/2016 |
04/30/2015 |
| Operating Revenue |
$139.91 M |
$149.27 M |
$119.60 M |
$95.87 M |
$59.70 M |
$53.60 M |
$53.62 M |
$57.63 M |
$44.69 M |
$26.78 M |
| Cost of Revenue |
$132.59 M
|
$117.79 M
|
$82.95 M
|
$66.56 M
|
$55.77 M
|
$46.38 M
|
$56.55 M
|
$38.26 M
|
$22.97 M
|
$15.59 M
|
| Gross Profit |
$7.32 M
|
$31.48 M
|
$36.65 M
|
$29.31 M
|
$3.93 M
|
$7.22 M
|
-$2.92 M
|
$19.37 M
|
$21.72 M
|
$11.19 M
|
| Gross Profit Ratio |
0.05
|
0.21
|
0.31
|
0.31
|
0.07
|
0.13
|
-0.05
|
0.34
|
0.49
|
0.42
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$28.30 M
|
$59.53 M
|
$43.00 M
|
| General & Administrative Expenses |
$25.20 M
|
$27.18 M
|
$20.63 M
|
$16.76 M
|
$14.32 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$800.00 K
|
$700.00 K
|
$600.00 K
|
$300.00 K
|
$200.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$26.00 M
|
$27.88 M
|
$21.23 M
|
$17.06 M
|
$14.52 M
|
$12.85 M
|
$16.46 M
|
$19.33 M
|
$18.55 M
|
$18.69 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$81.00 K
|
$133.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$26.00 M
|
$27.88 M
|
$21.23 M
|
$17.06 M
|
$14.52 M
|
$12.85 M
|
$16.46 M
|
$47.63 M
|
$78.08 M
|
$61.69 M
|
| Cost And Expenses |
$158.59 M
|
$145.67 M
|
$104.18 M
|
$83.63 M
|
$70.29 M
|
$59.23 M
|
$73.00 M
|
$85.89 M
|
$101.05 M
|
$77.28 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$133.00 K
|
$474.00 K
|
$293.00 K
|
$102.00 K
|
$108.00 K
|
$124.00 K
|
$142.00 K
|
| Interest Expense |
$4.34 M
|
$3.01 M
|
$2.68 M
|
$1.16 M
|
$8.00 K
|
$11.00 K
|
$27.00 K
|
$7.00 K
|
$14.00 K
|
$1.00 K
|
| Depreciation & Amortization |
$11.11 M
|
$7.21 M
|
$4.48 M
|
$3.45 M
|
$3.09 M
|
$2.75 M
|
$2.56 M
|
$2.46 M
|
$1.54 M
|
$1.04 M
|
| EBITDA |
-$11.48 M |
$10.91 M |
$19.90 M |
$15.70 M |
-$7.38 M |
-$2.59 M |
-$16.82 M |
$3.76 M |
$5.02 M |
-$49.32 M |
| EBITDA Ratio |
-0.08
|
0.07
|
0.17
|
0.16
|
-0.12
|
-0.05
|
-0.31
|
0.07
|
0.11
|
-1.84
|
| Operating Income Ratio |
-0.13
|
-0.02
|
0.09
|
0.09
|
-0.18
|
-0.1
|
-0.38
|
-0.49
|
-1.26
|
-1.89
|
| Total Other Income/Expenses Net |
-$8.25 M
|
-$2.01 M
|
-$2.76 M
|
-$1.03 M
|
$119.00 K
|
$282.00 K
|
$75.00 K
|
$101.00 K
|
$708.00 K
|
$141.00 K
|
| Income Before Tax |
-$26.93 M
|
$2.00 M
|
$12.66 M
|
$11.21 M
|
-$10.47 M
|
-$5.34 M
|
-$20.56 M
|
-$28.16 M
|
-$55.65 M
|
-$50.36 M
|
| Income Before Tax Ratio |
-0.19
|
0.01
|
0.11
|
0.12
|
-0.18
|
-0.1
|
-0.38
|
-0.49
|
-1.25
|
-1.88
|
| Income Tax Expense |
$113.83 M
|
$1.44 M
|
-$115.01 M
|
-$2.29 M
|
-$3.21 M
|
-$284.00 K
|
$0.00
|
-$2.36 M
|
$722.00 K
|
$142.00 K
|
| Net Income |
-$140.75 M
|
$560.00 K
|
$127.67 M
|
$11.21 M
|
-$7.26 M
|
-$4.22 M
|
-$21.81 M
|
-$28.16 M
|
-$55.65 M
|
-$50.36 M
|
| Net Income Ratio |
-1.01
|
0
|
1.07
|
0.12
|
-0.12
|
-0.08
|
-0.41
|
-0.49
|
-1.25
|
-1.88
|
| EPS |
-2.23 |
0.009 |
2.08 |
0.057 |
-0.13 |
-0.0753 |
-0.46 |
-0.76 |
-1.8 |
-1.93 |
| EPS Diluted |
-2.23 |
0.0088 |
1.81 |
0.0558 |
-0.13 |
-0.0753 |
-0.46 |
-0.76 |
-1.8 |
-1.93 |
| Weighted Average Shares Out |
$63.20 M
|
$62.27 M
|
$61.48 M
|
$58.22 M
|
$56.33 M
|
$55.98 M
|
$47.06 M
|
$37.11 M
|
$30.90 M
|
$26.08 M
|
| Weighted Average Shares Out Diluted |
$63.20 M
|
$63.78 M
|
$70.47 M
|
$59.43 M
|
$56.33 M
|
$55.98 M
|
$47.06 M
|
$37.11 M
|
$30.90 M
|
$26.08 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
